Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Upgrades Lowe's (LOW) to Hold
-
Keurig Green Mountain (GMCR) Numbers Raised at Canaccord Genuity Ahead of Q4 Print
-
Streetinsider.com's Hot Lunchtime Reads 11/17: (BBRY) (ACT) (GSAT) (SNSS)
-
BlackBerry (BBRY) Still Early on Road to Recovery and Sustainable Proifts, Canaccord Genuity Says
-
Notable Analyst Rating Changes 11/17: (MTG) (PSX) (CHK) Upgraded; (NOK) (ODP) (WTSL) Downgraded
-
Pre-Open Stock Movers 11/17: (CLDX) (BHI) (AGN) Higher; (DWA) (GSAT) (HAL) Lower (more...)
-
Canaccord Genuity Downgrades Procter & Gamble (PG) to Hold
-
Canaccord Genuity Starts Mast Therapeutics (MSTX) at Buy
-
Notable Analyst Rating Changes 11/14: (RTN) (ESRT) (GERN) Upgraded; ((TJX) (LULU) (WMT) Downgraded
-
UPDATE: Canaccord Genuity Downgrades The TJX Companies (TJX) to Sell
-
Canaccord Genuity Downgrades Ross Stores, Inc. (ROST) to Sell
-
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
-
LeMaitre Vascular to Participate in Three Investor Conferences in November 2014
-
Notable 52-Week Highs and Lows of the Day 11/12: (AAPL) (ACHN) (AGIO) High; (SEAS) (SFY) (ASPS) Low
-
Notable Analyst Rating Changes 11/12: (QLTY) (DHR) (FI) Upgraded; (JBLU) (CBOE) (HCA) Downgraded
-
Canaccord Genuity Starts Agios Pharma (AGIO) at Buy
-
Intersect ENT to Present at Canaccord Genuity and Piper Jaffray Conferences
-
Cutera to Present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum and the Piper Jaffray 26th Annual Healthcare Conference
-
Canaccord Keeps NPS Pharma (NPSP) at 'Buy'; Some Centers Slower to Put Patients on Gattex
-
Canaccord Genuity Remains Unconvinced About Rackspace (RAX) Recovery
-
TearLab to Participate in November Investor Conferences
-
Xenon Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Sunshine Heart to Present at Upcoming Investor Conferences
-
Merit Medical to Present at Stephens and Canaccord Genuity Conferences This Month
-
Freshpet (FRPT) IPO Opens Up 32%
-
ORBCOMM (ORBC) Prices 12.9M Common Offering at $5.60/Share
-
Freshpet (FRPT) IPO Prices Above Expected Range
-
ORBCOMM (ORBC) Announces $72M Common Stock Offering
-
Canaccord Genuity Downgrades Lifetime Brands (LCUT) to Hold
-
Canaccord Genuity Names Dennis Miller to Board, Expanding Independant Directors to 8
-
Upland Software (UPLD) IPO Opens 8% Lower
-
Notable Analyst Rating Changes 11/6: (DATA) (MDLZ) (CMLP) Upgraded; (CDE) (DUK) (AEP) Downgraded
-
Canaccord Genuity Starts Transocean (RIG) at Sell
-
Medigus to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum in NYC
-
ReWalk Robotics to Present at Upcoming November Conferences
-
Xenon Pharmaceuticals (XENE) IPO Opens Higher
-
Nu Skin Enterprises (NUS) Can't Be Bought Until China Bottoms, Canaccord Genuity Says
-
Xenon Pharmaceuticals Announces Pricing of Initial Public Offering
-
UPDATE: PhotoMedex (PHMD) Retains Advisor to Evaluate Strategic Options
-
Canaccord Genuity Downgrades Lumber Liquidators (LL) to Hold
-
Canaccord Genuity Starts HubSpot Inc (HUBS) at Buy
-
Canaccord Genuity Downgrades STAAR Surgical (STAA) to Hold
-
Canaccord Genuity Downgrades Bottomline Technologies (EPAY) to Hold
-
Canaccord Genuity Upgrades RF Micro Devices (RFMD) to Buy
-
Canaccord Genuity Upgrades TriQuint Semiconductor (TQNT) to Buy
-
Canaccord Genuity Upgrades SunPower (SPWR) to Buy
-
Vanda Pharmaceuticals (VNDA) Prices 5M Offering at $11.60/Share
-
Canaccord Genuity Downgrades Midway Gold (MDW) to Hold
-
Canaccord Genuity Downgrades Aspen Technology (AZPN) to Hold
-
Canaccord Trims Price Target on Coach (COH) to $34 Following Q3 Results

